539 news items
Page 8 of 27
k3nx41j
9 Apr 24
vaccine in different colorectal cancer models" | Abstract 5003
k2sbirk3df6
XNCR
9 Apr 24
), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced
bwuxnkf 2e4ci6r1e4
YS
9 Apr 24
, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced positive
j2xsiqs5gumd545td9uikw20c1m63eilxt
CLDI
9 Apr 24
mechanisms of action underlying the immunomodulatory role of Calidi's therapies at the American Association for Cancer Research Annual (AACR) Meeting 2024
gqm0loqaupl7i5lm8874cud8yas6safl81ihrznehyr9j
9 Apr 24
cancer-specific T-cell amplifying efficacy when combined with standard of care colorectal cancer therapy
zzmiqdjewc xlj
9 Apr 24
confidence in the potential for our dendritic cell vaccines to significantly improve the lives of patients with the most deadly cancers," said Mike
dd7do bvahkh1x03jepjtql204y32yn1v04mmfff008kmhxkklaf61vzd
8 Apr 24
therapeutic cancer vaccine, combined with LIBTAYO, an anti-PD1 checkpoint inhibitor (CPI). The data were generated in the OpcemISA trial, a large-scale
drs2li9a1nalinq4 nr7foz8dbxm1mhe1xh8qjftproo4gd7spvuuiu0l
GRTS
8 Apr 24
on March 1, 2024. Then, on April 1, 2024, Gritstone reported mixed preliminary Phase 2 data for its personalized cancer vaccine
ri7m6b6dfhl5bhe1cwvoyrhm07z69
8 Apr 24
, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled "Pet Cancer Therapeutics Market Size, Trends
zqiw oja5blo
MRK
8 Apr 24
cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales
tw0ji28 ag3ou1y6pkfefi6xqlhk77chpfjlenyc4ty89yy4z99suo47fcrw
GRTS
8 Apr 24
Location: Virtual Canaccord Genuity Horizons in Oncology Virtual Conference (Panel)Panel Title: Cancer Vaccines
ovjp gfx9uhw5it6rxmg622dfpx0h3e3typa1403xkh46u
SCNI
8 Apr 24
of liposomal therapeutics for the treatment of cancer and other diseases. Its flagship product, Doxorubicin HCl Liposome Injection, is FDA-approved
iznka5r4yh7jyqrvxqp9djhlzlfwe8qvsqestp0kyy9wv2ws hu6dso9
BNTX
8 Apr 24
Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran
9cpwjn9pza cf
7 Apr 24
on the development of personalized therapeutic cancer vaccines (PTCVs), today announced the publication of positive safety, immunogenicity, and efficacy data
cbmglf3vol6qqx8jhjabou3upci26 t19c945kd2giiz57dtqxy81
BNTX
7 Apr 24
-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122
g3kua828hd 33ktb
LEGN
5 Apr 24
is an incurable and progressive hematologic cancer that causes patients to relapse and become refractory to treatment, so new, innovative options
wjlpb8n9zymvne okp88
JNJ
5 Apr 24
."
More than 35,000 estimated new cases of multiple myeloma, an incurable blood cancer, will be diagnosed in 2024
2vd6r6jjn3vqsjl3n5tudxr5wgwy7ytohc8krncuv5km46qpt
ELTX
5 Apr 24
, an off-the-shelf investigational therapeutic cancer vaccine for patients with mutant Kirsten rat sarcoma ("mKRAS")-driven pancreatic and colorectal
pcxwdyu1hgfh9to8dj0cvox25wapk7nslw7ifelyt6xucu
ELTX
5 Apr 24
of ELI-002, an off-the-shelf investigational therapeutic cancer vaccine for patients with mutant Kirsten rat sarcoma ("mKRAS")-driven pancreatic
73oxgrea439kra7vuvzrr7i37fj0cxntnq1v6ucn2
5 Apr 24
the research surrounding breast cancer vaccines. After a conversation with Nora Disis, M.D., from the University of Washington's Cancer Vaccine